Combined Modality Treatment of Adductor Spasmodic Dysphonia
Results and Conclusions
Significant effects were observed on perceived quality of life and acoustic variables for all participants, over time. Participants who received voice therapy after BTX-A injection did not experience longer injection effect duration or significantly greater improvements in V-RQOL or acoustic variables than participants in BTX-A only or BTX-A plus sham therapy groups. Additionally, perceptual ratings of voice quality improved for all participants in response to BTX-A injection. For participants in this investigation, undertaking voice therapy did not appear to exert significant beneficial effects on the variables of interest.
from the Journal of Voice
Posted on February 8, 2011, in Research and tagged acoustic, Adductor spasmodic dysphonia, Botulinum, quality of life, Signal typing, speech pathology, voice, Voice disorder, voice therapy. Bookmark the permalink. Leave a comment.